FI932789A0 - Emättimensisäinen antosysteemi - Google Patents

Emättimensisäinen antosysteemi

Info

Publication number
FI932789A0
FI932789A0 FI932789A FI932789A FI932789A0 FI 932789 A0 FI932789 A0 FI 932789A0 FI 932789 A FI932789 A FI 932789A FI 932789 A FI932789 A FI 932789A FI 932789 A0 FI932789 A0 FI 932789A0
Authority
FI
Finland
Prior art keywords
pct
core member
support means
sec
administration system
Prior art date
Application number
FI932789A
Other languages
English (en)
Swedish (sv)
Other versions
FI95768C (fi
FI95768B (fi
FI932789A (fi
Inventor
Matti Lehtinen
Christine Talling
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of FI932789A0 publication Critical patent/FI932789A0/fi
Priority to FI932789A priority Critical patent/FI95768C/fi
Priority to ES94917022T priority patent/ES2130423T3/es
Priority to MYPI94001519A priority patent/MY113965A/en
Priority to HU9503290A priority patent/HU217950B/hu
Priority to CZ953208A priority patent/CZ284989B6/cs
Priority to TW083105534A priority patent/TW286273B/zh
Priority to PL94312193A priority patent/PL176664B1/pl
Priority to JP52252194A priority patent/JP3803714B2/ja
Priority to AT94917022T priority patent/ATE177657T1/de
Priority to DK94917022T priority patent/DK0703802T3/da
Priority to RU96101160A priority patent/RU2121824C1/ru
Priority to CA002165282A priority patent/CA2165282C/en
Priority to AU68481/94A priority patent/AU674758B2/en
Priority to EP94917022A priority patent/EP0703802B1/en
Priority to US08/564,253 priority patent/US5694947A/en
Priority to BR9407118A priority patent/BR9407118A/pt
Priority to DE69417232T priority patent/DE69417232T2/de
Priority to KR1019950705668A priority patent/KR100312764B1/ko
Priority to CN94192420A priority patent/CN1126574C/zh
Priority to PCT/FI1994/000255 priority patent/WO1995000199A1/en
Priority to LTIP1957A priority patent/LT3455B/lt
Priority to EE9400027A priority patent/EE03202B1/xx
Publication of FI932789A publication Critical patent/FI932789A/fi
Priority to NO19955029A priority patent/NO311498B1/no
Application granted granted Critical
Publication of FI95768B publication Critical patent/FI95768B/fi
Publication of FI95768C publication Critical patent/FI95768C/fi
Priority to GR990401648T priority patent/GR3030565T3/el
Priority to LVP-99-169A priority patent/LV12452B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Paper (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Details Of Garments (AREA)
  • Particle Formation And Scattering Control In Inkjet Printers (AREA)
FI932789A 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi FI95768C (fi)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FI932789A FI95768C (fi) 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi
AU68481/94A AU674758B2 (en) 1993-06-17 1994-06-15 Intravaginal delivery system
US08/564,253 US5694947A (en) 1993-06-17 1994-06-15 Intravaginal delivery system
HU9503290A HU217950B (hu) 1993-06-17 1994-06-15 Intravaginális adagolórendszer és eljárás annak előállítására
CZ953208A CZ284989B6 (cs) 1993-06-17 1994-06-15 Intravaginální dodávací systém, jeho použití a způsob jeho přípravy
TW083105534A TW286273B (fi) 1993-06-17 1994-06-15
PL94312193A PL176664B1 (pl) 1993-06-17 1994-06-15 Przyrząd do podawania dopochwowego oraz sposób wytwarzania tego przyrządu
JP52252194A JP3803714B2 (ja) 1993-06-17 1994-06-15 膣内薬剤放出システム
AT94917022T ATE177657T1 (de) 1993-06-17 1994-06-15 Intravaginales wirkstoffabgabesystem
DK94917022T DK0703802T3 (da) 1993-06-17 1994-06-15 Intravaginalt system til afgivelse af aktivt stof
RU96101160A RU2121824C1 (ru) 1993-06-17 1994-06-15 Внутривлагалищная система доставки
CA002165282A CA2165282C (en) 1993-06-17 1994-06-15 Intravaginal delivery system
ES94917022T ES2130423T3 (es) 1993-06-17 1994-06-15 Sistema de administracion intravaginal.
EP94917022A EP0703802B1 (en) 1993-06-17 1994-06-15 Intravaginal delivery system
MYPI94001519A MY113965A (en) 1993-06-17 1994-06-15 Intravaginal delivery system
BR9407118A BR9407118A (pt) 1993-06-17 1994-06-15 Sistema de tratamento intravaginal e método para preparar o sistema de tratamento intravaginal
DE69417232T DE69417232T2 (de) 1993-06-17 1994-06-15 Intravaginales wirkstoffabgabesystem
KR1019950705668A KR100312764B1 (ko) 1993-06-17 1994-06-15 질내전달시스템
CN94192420A CN1126574C (zh) 1993-06-17 1994-06-15 阴道内释放系统
PCT/FI1994/000255 WO1995000199A1 (en) 1993-06-17 1994-06-15 Intravaginal delivery system
LTIP1957A LT3455B (en) 1993-06-17 1994-06-16 Intravaginal delivery system of active agent
EE9400027A EE03202B1 (et) 1993-06-17 1994-07-18 Intravaginaalne manustussüsteem ja selle valmistamismeetod
NO19955029A NO311498B1 (no) 1993-06-17 1995-12-12 Intravaginalt avleveringssystem, samt fremgangsmåte for dets fremstilling
GR990401648T GR3030565T3 (en) 1993-06-17 1999-06-17 Intravaginal delivery system
LVP-99-169A LV12452B (en) 1993-06-17 1999-12-01 ACTIVE SUBSTANCE VAGINARY ADMINISTRATION SYSTEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI932789A FI95768C (fi) 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi

Publications (4)

Publication Number Publication Date
FI932789A0 true FI932789A0 (fi) 1993-06-17
FI932789A FI932789A (fi) 1994-12-18
FI95768B FI95768B (fi) 1995-12-15
FI95768C FI95768C (fi) 1996-03-25

Family

ID=8538154

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932789A FI95768C (fi) 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi

Country Status (24)

Country Link
US (1) US5694947A (fi)
EP (1) EP0703802B1 (fi)
JP (1) JP3803714B2 (fi)
KR (1) KR100312764B1 (fi)
CN (1) CN1126574C (fi)
AT (1) ATE177657T1 (fi)
AU (1) AU674758B2 (fi)
BR (1) BR9407118A (fi)
CZ (1) CZ284989B6 (fi)
DE (1) DE69417232T2 (fi)
DK (1) DK0703802T3 (fi)
EE (1) EE03202B1 (fi)
ES (1) ES2130423T3 (fi)
FI (1) FI95768C (fi)
GR (1) GR3030565T3 (fi)
HU (1) HU217950B (fi)
LT (1) LT3455B (fi)
LV (1) LV12452B (fi)
MY (1) MY113965A (fi)
NO (1) NO311498B1 (fi)
PL (1) PL176664B1 (fi)
RU (1) RU2121824C1 (fi)
TW (1) TW286273B (fi)
WO (1) WO1995000199A1 (fi)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
EP1100669B1 (en) * 1998-05-01 2005-12-21 Duramed Pharmaceuticals, Inc. Method for injection molding manufacture of controlled release devices and controlled release device
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
GB0009914D0 (en) 2000-04-20 2000-06-07 Metris Therapeutics Limited Device
US20070043332A1 (en) * 2003-07-10 2007-02-22 Galen (Chemiclas) Liimited Intravaginal drug delivery devices
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US8173593B2 (en) 2005-07-19 2012-05-08 The Population Council, Inc. Methods and compositions for emergency contraception using endothelin receptor antagonists
EP2097063B1 (en) * 2006-11-20 2013-08-07 Intervet International B.V. Helically-shaped drug delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
US20110045076A1 (en) * 2008-01-25 2011-02-24 Kiser Patrick F Linear order release polymer
SI2359807T1 (sl) 2008-02-04 2017-10-30 Ferring B.V. Monolitni intravaginalni obroč, ki vsebuje progesteron ter postopki za njegovo izdelavo in uporabo
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI20095563A (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
EP4108216A1 (en) 2009-06-03 2022-12-28 Forsight Vision5, Inc. Anterior segment drug delivery
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
WO2013029194A1 (es) 2011-08-26 2013-03-07 Universidad De Santiago De Chile Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer
GB201115592D0 (en) * 2011-09-09 2011-10-26 Vivosens Medical Gmbh Flexible ring pessary
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
CN103007427B (zh) * 2011-09-21 2016-01-20 上海市计划生育科学研究所 缓控释宫内释药器及其制备方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2641602A1 (en) 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2014032199A1 (es) 2012-09-03 2014-03-06 Ecosea Farming S.A. Sistema de hundimiento de balsa-jaula destinadas al cultivo y/o confinamiento de especies hidrobiologicas
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
UY35528A (es) 2013-04-10 2014-09-30 Preglem Sa Moduladores del receptor de la progesterona para uso en la terapia de fibromas uterinos
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US20170020718A1 (en) * 2014-04-01 2017-01-26 Poly-Med, Inc. Contraceptive and related device
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
KR20220061253A (ko) 2014-06-26 2022-05-12 타리스 바이오메디컬 엘엘씨 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN110403565B (zh) * 2018-04-27 2022-02-11 西安交通大学医学院第一附属医院 一种胶囊内窥镜磁与麦芒仿生双驱动装置
CN109771124A (zh) * 2019-01-31 2019-05-21 山东省药学科学院 一种具有形状记忆功能的子宫托
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1264731A (en) * 1917-03-19 1918-04-30 Carl Willers Pneumatic die-cushion.
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3911911A (en) * 1969-06-16 1975-10-14 Reese Hospital Michael Anti-fertility device
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
GB1465684A (en) * 1973-07-27 1977-02-23 Emmett L Contraceptive device
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
DE2616064A1 (de) * 1976-04-09 1977-10-20 Schering Ag Vaginalring iii
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ATE21331T1 (de) * 1981-12-30 1986-08-15 Population Council Inc Verfahren zur herstellung von intrauterinen vorrichtungen.
JPS5919151U (ja) * 1982-07-28 1984-02-06 ニツポ−株式会社 痔疾治療器
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US4822161A (en) * 1988-01-19 1989-04-18 Jimmy Michael F Illuminating spectacle apparatus
JPH02185264A (ja) * 1988-12-16 1990-07-19 Ferring Bv 膀胱内又は尿管へ薬を送り込む方法及び装置
KR100236355B1 (ko) * 1990-03-16 2000-01-15 이데이 노부유끼 와이프 패턴의 발생장치
JP3186105B2 (ja) * 1991-07-26 2001-07-11 日本電気株式会社 半導体装置のテストモード設定・解除回路
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
RU2121824C1 (ru) 1998-11-20
AU674758B2 (en) 1997-01-09
LV12452A (lv) 2000-04-20
WO1995000199A1 (en) 1995-01-05
HU217950B (hu) 2000-05-28
NO955029L (no) 1995-12-12
EE03202B1 (et) 1999-08-16
LV12452B (en) 2000-09-20
EP0703802A1 (en) 1996-04-03
KR960703024A (ko) 1996-06-19
FI95768C (fi) 1996-03-25
TW286273B (fi) 1996-09-21
EP0703802B1 (en) 1999-03-17
AU6848194A (en) 1995-01-17
CZ320895A3 (en) 1996-07-17
MY113965A (en) 2002-07-31
CZ284989B6 (cs) 1999-04-14
FI95768B (fi) 1995-12-15
DK0703802T3 (da) 1999-10-11
KR100312764B1 (ko) 2002-11-23
LTIP1957A (en) 1995-01-31
DE69417232T2 (de) 1999-11-04
BR9407118A (pt) 1996-09-03
ES2130423T3 (es) 1999-07-01
JPH08511240A (ja) 1996-11-26
LT3455B (en) 1995-10-25
PL312193A1 (en) 1996-04-01
CN1125403A (zh) 1996-06-26
HU9503290D0 (en) 1996-01-29
ATE177657T1 (de) 1999-04-15
US5694947A (en) 1997-12-09
NO955029D0 (no) 1995-12-12
NO311498B1 (no) 2001-12-03
FI932789A (fi) 1994-12-18
PL176664B1 (pl) 1999-07-30
HUT74548A (en) 1997-01-28
GR3030565T3 (en) 1999-10-29
JP3803714B2 (ja) 2006-08-02
DE69417232D1 (de) 1999-04-22
CN1126574C (zh) 2003-11-05

Similar Documents

Publication Publication Date Title
FI95768B (fi) Emättimensisäinen antosysteemi
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
GB9203037D0 (en) Contrast agents
MY124695A (en) Novel composition and use.
FI954989A (fi) Lääkelaastari
SE7714066L (sv) Tillforselenhet for biologiskt aktiva emnen
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
EP0869801A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
NO305440B1 (no) Gestagent aktive 19,11-broede 4-°strener
ES2152315T3 (es) Xamoneline tartrato.
CA2165282A1 (en) Intravaginal delivery system
MX9701031A (es) Utilizacion de la selegilina para el tratamiento de enfermedades epilepticas.
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
MX9803093A (es) Suministro de polipeptidos biologicamente activos.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA OY

Free format text: BAYER SCHERING PHARMA OY